These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2696487)

  • 1. Immunoadjuvants and analogs of immunomodulatory bacterial structures.
    Lise LD; Audibert F
    Curr Opin Immunol; 1989 Dec; 2(2):269-74. PubMed ID: 2696487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvants: update on concepts].
    Berinstein A; Sadir AM
    Rev Argent Microbiol; 1990; 22(3):159-66. PubMed ID: 2102016
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of action by immunologic adjuvants.
    Osebold JW
    J Am Vet Med Assoc; 1982 Nov; 181(10):983-7. PubMed ID: 6294032
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier.
    Przewlocki G; Audibert F; Jolivet M; Chedid L; Kent SB; Neurath AR
    Biochem Biophys Res Commun; 1986 Oct; 140(2):557-64. PubMed ID: 3778467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antibody response to bovine herpesvirus 1 with non-specific immunostimulants.
    Hampl J; Franz J; Stĕpánek J; Toman M
    Vet Med (Praha); 1996 May; 41(5):143-7. PubMed ID: 8693667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local cellular reactions following intracutaneous injections of various adjuvants in rats and guinea-pigs.
    Wachsmuth ED
    Adv Exp Med Biol; 1979; 114():451-7. PubMed ID: 463656
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rational method for producing sera with high titers of virus-neutralizing antibodies. Part III].
    Kravchenko AT; Tsetlin EM; Omel'chenko TN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):50-4. PubMed ID: 6254289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of immunological adjuvants.
    Warren HS; Vogel FR; Chedid LA
    Annu Rev Immunol; 1986; 4():369-88. PubMed ID: 2871847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological aspects of immunostimulants].
    Eichelberg D; Schmutzler W
    Immun Infekt; 1983 Jun; 11(4):109-22. PubMed ID: 6085319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
    Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
    Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of H-2-restricted hyporesponsiveness to human growth hormone by the use of aluminum hydroxide as adjuvant.
    Bomford R; Aston R; Ivanyi J
    Immunogenetics; 1985; 21(5):505-9. PubMed ID: 2581892
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice.
    Katz D; Lehrer S; Galan O; Lachmi BE; Cohen S
    FEMS Microbiol Immunol; 1991 Nov; 3(6):305-20. PubMed ID: 1812932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
    J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of IgE antibody formation in mice with nonspecific stimulation.
    Itaya T; Tomioka H; Kumagai A; Tada T
    Int Arch Allergy Appl Immunol; 1980; 62(4):389-96. PubMed ID: 7380577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera].
    Kozlov VG; Viktorova EG
    Vopr Virusol; 2011; 56(2):41-6. PubMed ID: 21545042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus).
    Vinay TN; Park CS; Kim HY; Jung SJ
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):73-85. PubMed ID: 23570990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freund's complete adjuvant: an effective but disagreeable formula.
    Claassen E; de Leeuw W; de Greeve P; Hendriksen C; Boersma W
    Res Immunol; 1992 Jun; 143(5):478-83; discussion 572. PubMed ID: 1439126
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of the immunological adjuvant effect of vaccinia-virus].
    Bandlow G; Fischer W; Thomssen R
    Arch Gesamte Virusforsch; 1972; 38(2):192-204. PubMed ID: 4198012
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of adjuvants that enhance the therapeutic antibody response to host IgE.
    Johansson J; Ledin A; Vernersson M; Lövgren-Bengtsson K; Hellman L
    Vaccine; 2004 Jul; 22(21-22):2873-80. PubMed ID: 15246623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.